Abstract
Aims
To investigate the expression of human telomerase gene RNA (hTR) and human telomerase reverse transcriptase (hTRT) in eyelid sebaceous gland carcinoma and to evaluate risk factors for sebaceous carcinoma recurrence.
Methods
The expression patterns of hTR and hTRT were detected by in situ hybridization (ISH) in paraffin-embedded samples of 55 eyelid sebaceous gland carcinoma, 12 chalazia, and four sebaceous adenoma. The proliferation index (PI) of sebaceous gland carcinoma was determined by Ki-67 immunolabeling and the results were compared with the expression of hTR and hTRT. Several factors for recurrence of sebaceous gland carcinoma were evaluated by statistical analysis.
Results
Expression of hTR and hTRT was present mainly in the sebaceous gland carcinoma tissues and not in adjacent tissues of carcinoma, chalazia, and sebaceous adenoma. The prevalence of hTR, hTRT, and Ki-67 expression in 55 sebaceous carcinoma samples were 84.45%, 58.1%, and 78.18%, respectively. hTR expression was highly associated with the degree of carcinoma differentiation (P<0.001) and hTRT expression was correlated with the proliferation index as determined by Ki-67 staining (P<0.005). There was a correlation between the recurrence of sebaceous gland carcinoma and the patient's onset age (OR=0.914, P<0.05), as well as the time to first treatment (OR=1.163, P<0.01).
Conclusions
Telomerase may play an important role in the carcinogenesis of sebaceous gland carcinoma, and expression of hTR and hTRT combined with other features of sebaceous gland carcinoma may be helpful for the diagnosis and evaluation of clinical prognosis. Risk factors for recurrence of sebaceous gland carcinoma are patients' onset age and the time to first treatment.
Similar content being viewed by others
References
Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:710–715
Greider CW, Blackburn EH (1989) A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337:331–337
Harle-Bachor C, Boukamp P (1996) Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci U S A 93:6476–6481
Hasebe T, Mukai K, Yamaguchi N, Ishihara K, Kaneko A, Takasaki Y, Shimosato Y (1994) Prognostic value of immunohistochemical staining for, proliferating cell nuclear antigen p53 and c-erb-2 in sebaceous gland carcinoma and sweet gland carcinoma: comparison with histopathological parameter. Mod Pathol 7:37–43
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015
Li B, Li N, Sun X, Li L, Chen C (2003) Clinical and histopathologic features in sebaceous gland carcinoma and analysis of prognostic predictors. Recent Adv Ophthalmol 23(2):117–119
Li B, Li N, Sun X, Li L, Chen C (2002) Telomerase expression in sebaceous carcinoma of the eyelid. Chinese J Ophthalmol 38(11):684–687
Li N, Li B, Sun X, Li L, Chen C (2002) Expression of the telomerase RNA correlates with the clinical prognostic analysis of tarsal gland carcinoma. Chinese Ophthalm Resh 20(6):498–501
Maitra A, Yashima K, Rathi A, Timmons CF, Rogers BB, Shay JW, Gazdar (1999) The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 85:741–749
Morin GB (1989) The human telomerase terminal transferase enzyme is a riboprotein that synthesizes TTAGGG repeats. Cell 59:521–529
Park TW, Riethdorf S, Riethdorf L, Loning T, Janicke F (1999) Differential telomerase activity, expression of the telomerase catalytic subunit and telomerase-RNA in ovarian tumors. Int J Cancer 84:426–431
Rao NA, Hidayat AA, McLean IW, Zimmerman LE (1982) Sebaceous carcinoma of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol 13(2):113–122
Rathi A, Hur K, Gazdar AF, Bae JS, Jang JJ, Kim DY (1999) Telomerase RNA expression during progression of gastric cancer. Human Pathol 1302–1307 (Nov 30)
Spencer WH (1985) Ophthalmic pathology, 3rd edn. Saunders, Philadelphia, pp 2201–2214
Wan M, Li WZ, Duggan BD, Felix JC, Zhao Y, Dubeau L (1997) Telomerase activity in benign and malignant epithelial ovarian tumors. J Natl Cancer Inst 89:437–441
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, B., Li, N., Cheng, G. et al. Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma. Graefe's Arch Clin Exp Ophthalmo 244, 480–484 (2006). https://doi.org/10.1007/s00417-005-0089-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-005-0089-1